Inhibiting the transient receptor potential A1 ion channel
申请人:HYDRA BIOSCIENCES, INC.
公开号:US10221177B2
公开(公告)日:2019-03-05
The present invention relates to pharmaceutical compounds of the Formula (I), or a pharmaceutically acceptable salt or composition thereof, and methods of their use for the treatment of pain, respiratory conditions, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).